| Style | Citing Format |
|---|---|
| MLA | M Askari MOHAMMADREZA, et al.. "Prevalence and Risk Factors of Abuse Among Older Adults Registered With Health Centers in Southern Tehran: A Population-Based Study." Aging Clinical and Experimental Research, vol. 37, no. 1, 2025, pp. -. |
| APA | M Askari MOHAMMADREZA, F Bahramnezhad FATEMEH, F Sharifi FARSHAD, E Navab ELHAM (2025). Prevalence and Risk Factors of Abuse Among Older Adults Registered With Health Centers in Southern Tehran: A Population-Based Study. Aging Clinical and Experimental Research, 37(1), -. |
| Chicago | M Askari MOHAMMADREZA, F Bahramnezhad FATEMEH, F Sharifi FARSHAD, E Navab ELHAM. "Prevalence and Risk Factors of Abuse Among Older Adults Registered With Health Centers in Southern Tehran: A Population-Based Study." Aging Clinical and Experimental Research 37, no. 1 (2025): -. |
| Harvard | M Askari MOHAMMADREZA et al. (2025) 'Prevalence and Risk Factors of Abuse Among Older Adults Registered With Health Centers in Southern Tehran: A Population-Based Study', Aging Clinical and Experimental Research, 37(1), pp. -. |
| Vancouver | M Askari MOHAMMADREZA, F Bahramnezhad FATEMEH, F Sharifi FARSHAD, E Navab ELHAM. Prevalence and Risk Factors of Abuse Among Older Adults Registered With Health Centers in Southern Tehran: A Population-Based Study. Aging Clinical and Experimental Research. 2025;37(1):-. |
| BibTex | @article{ author = {M Askari MOHAMMADREZA and F Bahramnezhad FATEMEH and F Sharifi FARSHAD and E Navab ELHAM}, title = {Prevalence and Risk Factors of Abuse Among Older Adults Registered With Health Centers in Southern Tehran: A Population-Based Study}, journal = {Aging Clinical and Experimental Research}, volume = {37}, number = {1}, pages = {-}, year = {2025} } |
| RIS | TY - JOUR AU - M Askari MOHAMMADREZA AU - F Bahramnezhad FATEMEH AU - F Sharifi FARSHAD AU - E Navab ELHAM TI - Prevalence and Risk Factors of Abuse Among Older Adults Registered With Health Centers in Southern Tehran: A Population-Based Study JO - Aging Clinical and Experimental Research VL - 37 IS - 1 SP - EP - PY - 2025 ER - |